US 11,547,765

Application 16/787,938 · Granted Jan 10, 2023

Optimized mini-dystrophin genes and expression cassettes and their use

Estimated expiration

June 20, 2037

10y 214d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Jun 20, 2017
+ 20 years
Jun 20, 2037
PTA +0d
Jun 20, 2037
No TD
—
Final
Jun 20, 2037

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
February 11, 2020
Earliest effective filing
June 20, 2017
Issue date
January 10, 2023
PTA
0 days
Base expiry (before PTA)
June 20, 2037

June 20, 2017 + 20 years = June 20, 2037

  • Continuation of application 15/628,268, filed Jun 20, 2017
  • PRO62/352,675 — Provisional — not used for base term
  • PRO62/516,449 — Provisional — not used for base term
  • PRO62/352,675 — Provisional — not used for base term
  • PRO62/516,449 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 16/787,938 · US 11,547,765

PatentReply compiles the prosecution history behind US 11,547,765: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US11547765

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.